JENNA BLASZCZYK: Open Payments
NPI 1265120786 · JOLIET, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$697 in 19 payments from 13 companies in 2025. Trend: 2023 $574 · 2024 $759 · 2025 $697
Food & beverage: $396Education: $302
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $141 |
| Gilead Sciences, Inc. | 2 | $123 |
| SEAGEN INC. | 1 | $93 |
| Novartis Pharmaceuticals Corporation | 3 | $80 |
| EMD Serono, Inc. | 2 | $42 |
| PFIZER INC. | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 1 | $41 |
| TerSera Therapeutics LLC | 1 | $30 |
| Genentech USA, Inc. | 1 | $24 |
| Janssen Biotech, Inc. | 1 | $23 |
Products named: Trodelvy, IBRANCE, Fabhalta, Zoladex, KISQALI, Ocrevus Zunovo, TECVAYLI, PLUVICTO.
Industry payments across IL — which companies pay providers there.
